FGF23 and chronic kidney disease: One of these is the fibroblast growth factor 23 (FGF23), the levels of which negatively correlate with the glomerular function rate (GFR) in patients with CKD [6,7], and increased levels of this molecule have been associated with endocrine and metabolism dysregulation, as well as cardiovascular alterations [8,9].